Early treatment of Parkinson's disease Open studies are unreliableBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6923.272a (Published 22 January 1994) Cite this as: BMJ 1994;308:272
- V Myllyla,
- E Heinonen
- Department of Neurology, University Hospital of Oulu, Oulu, Finland Orion-Farmos Pharmaceuticals, Farmos Research, Neurological Products, Turku, Finland.
EDITOR, - We wish to comment on the article by the Parkinson's Disease Research Group in the United Kingdom on early treatment of the disease.1
Firstly, the study was open; open studies may undermine the reliability of clinical trials. The comparability of the three groups over time is a major concern in this trial: in the bromocriptine group there was a 69% drop out rate, whereas in the two other groups the drop out rate was around 30%. This may have diminished the comparability of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial